|4Sep 16, 4:10 PM ET

Medytox Inc. 4

4 · Evolus, Inc. · Filed Sep 16, 2022

Insider Transaction Report

Form 4
Period: 2022-09-14
Medytox Inc.
10% Owner
Transactions
  • Sale

    Common Stock, $0.00001 par value per share

    2022-09-15$10.34/sh24,000$248,1057,304,652 total
  • Sale

    Common Stock, $0.00001 par value per share

    2022-09-14$10.27/sh73,000$749,6747,328,652 total
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.10 to $10.54, inclusive. The reporting person undertakes to provide to Evolus, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnotes (1) and (2) to this Form 4.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.17 to $10.43, inclusive.

Documents

1 file
  • 4
    eols-form4_091422.xmlPrimary

    CHANGES IN BENEFICIAL OWNERSHIP